Products
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$49/mo
Higher than 72% of peersNiche median $19/mo
Creators
Jainan Singh
@roistackorg· 3 followers
Launched
4mo ago
2026-08-02 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
X accounts@roistackorg
  • Launched on Product HuntLaunch

    Practical AI, Automation & Growth Strategies

    Aug 2 · 4mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

  • Direct30%
  • Organic Search26%
  • Referrals12%
  • Display Ads9%
  • Other23%

Countries

  • United States88%
  • Pakistan12%

Search

Domain authority —Domain registered 2026-07-04

KeywordMonthly volume
google workspace1.8M
trello1.5M
xero841K
acrobat reader207.5K
trello board16.5K

Traffic data: Vaneform

Pricing

Starter
$49/mo
Professional
$99/mo
Enterprise
$249/mo

Trial: None · 3 paid tiers ($49–$249) · Observed 2026-11-06 · Pricing page

Entry price $49/mo, Higher than 72% of peers; “Accounting & Bookkeeping” median is $19/mo.View pricing benchmark

Website snapshots

Indexed 2026-08-02

Key pages

Desktop & mobile archive
roistack.org/ Snapshot 2026-11-06

Questions & evidence

How much does ROIStack cost?
Starter: $49/mo; Professional: $99/mo; Enterprise: $249/mo. Observed 2026-11-06. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does ROIStack get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is ROIStack and what platforms does it support?
ROIStack is catalogued under Accounting & Bookkeeping: Your AI CFO for Small Business Growth. Supported platforms: Web.

Related products in this category

Finance / Accounting & Bookkeeping

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.